Table I.
CD31 and CD11b ratios in non-small cell lung cancer xenografts.
| Group | CD31 ratio | CD11b ratio |
|---|---|---|
| F0 | 0.18±0.01a | 0.16±0.02a |
| F1 | 0.11±0.01 | 0.10±0.01 |
| F2 | 0.07±0.02 | 0.09±0.03 |
| F3 | 0.05±0.01 | 0.06±0.01 |
| F4 | 0.16±0.02a | 0.15±0.03a |
a
P<0.01 vs. F1, F2 and F3 groups. All data are presented as the mean ± standard deviation. CD, cluster of differentiation; F0, mice injected with A549 cells only; F1, mice injected with A549 cells and treated with B20 twice weekly; F2, mice transplanted with F1 tumor explant and treated with B20 twice weekly; F3, mice transplanted with F2 tumor explant and treated with B20 twice weekly; F4, mice transplanted with F3 tumor explant with no treatment.